Repare Therapeutics Inc.
RPTX
$1.42
$0.032.16%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -127.89M | -84.69M | -84.05M | -68.52M | -45.69M |
| Total Depreciation and Amortization | 2.61M | 1.92M | 1.97M | 1.99M | 2.01M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 18.61M | 20.38M | 20.99M | 21.52M | 20.81M |
| Change in Net Operating Assets | -10.83M | -14.06M | -16.19M | -34.60M | -60.57M |
| Cash from Operations | -117.51M | -76.45M | -77.28M | -79.61M | -83.44M |
| Capital Expenditure | -- | -- | -398.00K | -398.00K | -1.46M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 98.58M | 49.47M | 50.16M | 43.58M | 65.87M |
| Cash from Investing | 98.58M | 49.47M | 49.76M | 43.18M | 64.41M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 246.00K | 542.00K | 646.00K | 764.00K | 804.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 246.00K | 542.00K | 646.00K | 764.00K | 804.00K |
| Foreign Exchange rate Adjustments | -74.00K | -116.00K | 42.00K | -59.00K | -19.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -18.76M | -26.55M | -26.83M | -35.72M | -18.24M |